InvestorsHub Logo
Followers 8
Posts 1104
Boards Moderated 0
Alias Born 08/02/2011

Re: None

Wednesday, 11/09/2016 8:12:03 AM

Wednesday, November 09, 2016 8:12:03 AM

Post# of 6305
InVivo Therapeutics Announces University of Iowa Hospitals and Clinics as New Site for INSPIRE Study


CAMBRIDGE, Mass. (Nov 9, 2016) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that University of Iowa Hospitals and Clinics in Iowa City, IA, has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury. UI Hospitals and Clinics is a 732- bed hospital which, in fiscal year 2015, received more than 57,000 emergency room visits.

“Two active areas of spinal cord injury research involve timing and the use of biomaterials. The INSPIRE study represents the marriage of these two concepts and we look forward to participating,” said Patrick Hitchon, M.D., Professor in the departments of Neurosurgery and Biomedical Engineering and Principal Investigator at the study site. Saul Wilson, M.D., and Chandan Reddy, M.D. are co-investigators for the research trial.

Mark Perrin, InVivo’s CEO and Chairman, said, “We welcome Dr. Hitchon and his team to the INSPIRE study. This is the fourth new site we have announced in the last three weeks, and we look forward to bringing on more high-quality sites over the next several months.”

There are now 27 clinical sites participating in the clinical study:

Allegheny General Hospital, Pittsburgh, PA
Banner University Medical Center, Tucson, AZ
Barnes-Jewish Hospital at Washington University Medical Center, Louis, MO
Barrow Neurological Institute – Joseph’s Hospital and Medical Center, Phoenix, AZ
Ben Taub Hospital/Baylor College of Medicine, Houston, TX
Beth Israel Deaconess Medical Center, Boston, MA
Carolina Neurosurgery and Spine Associates/Carolinas Rehabilitation, Charlotte, NC
Cooper Neurological Institute, Camden, NJ
Foothills Medical Centre, Calgary, Alberta, Canada
Goodman Campbell Brain and Spine/Indiana University Health Neuroscience Center, Indianapolis, IN
Hospital of the University of Pennsylvania, Philadelphia, PA
Keck Hospital of University of Southern California, Los Angeles, CA
Medical College of Wisconsin/Froedtert Hospital, Milwaukee, WI
Mount Sinai Hospital, New York, NY
Northwestern Medicine, Chicago, IL
Oregon Health & Science University, Portland, OR
Rutgers New Jersey Medical School, Newark, NJ
Thomas Jefferson University Hospital, Philadelphia, PA
Toronto Western Hospital, Toronto, ON, Canada
University of California, Davis Medical Center, Sacramento, CA
University of California, San Diego Medical Center, San Diego, CA
University of Iowa Hospitals and Clinics, Iowa City, IA
University of Kansas Medical Center, Kansas City, KS
University of Louisville Hospital, Louisville, KY
University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA
University of Virginia Health System, Charlottesville, VA
Vidant Medical Center, Greenville, NC
For more information, please visit the company’s ClinicalTrials.gov registration site: http://clinicaltrials.gov/ct2/show/study/NCT02138110